Insider Transactions in Q2 2024 at Monopar Therapeutics (MNPR)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2024
|
Andrew Cittadine Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,019
-1.03%
|
$0
$0.73 P/Share
|
|
Jun 30
2024
|
Andrew Cittadine Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,952
+4.39%
|
-
|
|
Jun 30
2024
|
Chandler Robinson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,684
-3.16%
|
$0
$0.73 P/Share
|
|
Jun 30
2024
|
Chandler Robinson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,476
+8.18%
|
-
|
|
Jun 30
2024
|
Kim R Tsuchimoto Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,998
-4.96%
|
$0
$0.73 P/Share
|
|
Jun 30
2024
|
Kim R Tsuchimoto Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,957
+14.15%
|
-
|
|
Jun 20
2024
|
Andrew Cittadine Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
20,508
+9.92%
|
$0
$0.74 P/Share
|
|
Jun 18
2024
|
Andrew Cittadine Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
12,000
+6.76%
|
$0
$0.86 P/Share
|
|
Jun 17
2024
|
Andrew Cittadine Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
12,000
+7.25%
|
$0
$0.9 P/Share
|
|
Jun 14
2024
|
Andrew Cittadine Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
12,000
+7.81%
|
$0
$0.93 P/Share
|
|
Jun 13
2024
|
Andrew Cittadine Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
12,000
+8.47%
|
$0
$0.91 P/Share
|
|
Jun 04
2024
|
Andrew Cittadine Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
12,000
+9.26%
|
$0
$0.78 P/Share
|
|
Jun 03
2024
|
Andrew Cittadine Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
12,000
+10.2%
|
$0
$0.76 P/Share
|
|
May 31
2024
|
Andrew Cittadine Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
12,000
+11.36%
|
$0
$0.64 P/Share
|
|
May 30
2024
|
Andrew Cittadine Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
12,000
+12.82%
|
$0
$0.64 P/Share
|
|
May 29
2024
|
Andrew Cittadine Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
12,000
+14.7%
|
$0
$0.64 P/Share
|
|
May 28
2024
|
Chandler Robinson Chief Executive Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
84,000
+25.14%
|
-
|